Spun out f0fHarvard, AcousticaBio, Inc. is a preclinical biotechnology company structured around addressing significant challenges in delivery of novel therapeutics through its proprietary fluid processing technology. Backed by venture funding and NIH, management have established collaborations with leading global biopharmaceutical firms, demonstrating strong in vitro and in vivo safety and efficacy data. Led by a team of innovative experts, AcousticaBio is described as committed to building a better future in life sciences.
